Why is Metropolis Healt falling/rising?

As of 08-Jul, Metropolis Healthcare Ltd is experiencing a slight increase in its stock price, currently at 1,866.00, with a change of 2.35 (0.13%) upwards. The stock has shown strong performance recently, gaining 11.05% over the last seven days and outperforming its sector by 0.98% today. Additionally, it has outperformed the benchmark Sensex over the past week with a return of +9.25% compared to the Sensex's +0.02%. The stock's moving averages are higher than the 5-day, 20-day, 50-day, and 100-day averages, indicating positive momentum, although it remains below the 200-day moving average. The rising investor participation, evidenced by a significant increase in delivery volume, suggests growing interest in the stock.
In the broader market context, while Metropolis Healthcare has shown positive short-term returns, it has underperformed over the longer term, with a year-to-date decline of -9.56% compared to the Sensex's gain of +7.13%. The company has high management efficiency with a return on capital employed (ROCE) of 26.87% and low debt levels, which are favorable factors. However, the stock faces challenges due to poor long-term growth, as indicated by low net sales growth and disappointing recent financial results, including a significant drop in profit before tax and profit after tax. Despite these negative indicators, the stock's current valuation appears to be at a discount compared to its peers, which may attract investors looking for value opportunities.